The Most Unhappy Fella

  • by: |
  • 01/13/2007
Yesterday's vote on "government pricing" of prescription medicines garnered the fewest votes of Speaker Pelosi's "First 100 Hour" pieces of legislation. Legislators are seeing the light.

As Everett Dirkson was fond of saying, "When I feel the heat, I see the light."

And the heat is from America's seniors who are pleased with the Part D drug benefit.

And the heat is from, among other places, the Washington Post. Here is what America's lawmakers woke up to find in their own Newspaper of Record:

The Wrong Prescription
Government should not negotiate drug prices in Medicare.

HOUSE Democrats delivered on a campaign promise yesterday, passing a bill that would require the government to negotiate the price of pharmaceuticals covered by the new Medicare drug benefit. The idea is that government negotiators could force prices down, generating savings that could be used to make the benefit more generous. But the measure is misguided.

Here's a link to the complete editorial:

And the most unhappy fella in DC today is Rahm Emanuel -- sponsor of the Newspeak-named "Pharmaceutical Market Access and Drug Safety Act which demands "world pricing" as well as drug importation.

If only 24 Republicans voted for HR 4, the chances for Mr. Emanuel's legislation are about as good as Nancy Pelosi calling for a statue of Charlie the Tuna in Dupont Circle.

Here's what Mr. Emanuel's constituents woke up in today's Chicago Sun-Times:

Cheaper drugs would come at a steep price


U.S. Rep. Rahm Emanuel (D-Ill.) has announced legislation "aimed at driving down the price of prescription drugs." But the only thing such legislation would actually drive down is pharmaceutical innovation.

And here's the link to that article:,CST-EDT-REF13A.article

Even the New York Times is reporting that the Congressional Budget Office (CBO) study on "government pricing" shows that direct negotiations wouldn't save America's seniors any money.

America's legislators are beginning to feel the heat of truth and see the light of day -- that "government pricing" and quick fixes like drug importation are false promises -- and that the American people know it.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog